AlphaStocks
6.4
Consider Buy

Merck & Co., Inc. (MRK)

Health Care / Pharmaceuticals

S&P 500

$113.12

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#164out of 1126 in Health Care

Is Merck & Co., Inc. a Good Investment in 2026?

Merck & Co., Inc. (MRK) scores 6.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates Merck & Co., Inc. as Strong (Top 10% (rank 6%)). However, the Graham model rates it Caution — 93% above fair value. Merck & Co., Inc. ranks #164 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E15.5ROE35.0Market Cap280BDiv Yield2.9

Valuation

Trades at 16x earnings — near sector median of 26x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

93% above fair value

Lynch

Neutral

PEG 4.0 · Slow Grower

Greenblatt

Strong

Top 10% (rank 6%)

Frequently Asked Questions

Is Merck & Co., Inc. (MRK) a good investment?
Based on AlphaStocks' composite analysis, Merck & Co., Inc. (MRK) scores 6.4 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trades at 16x earnings — near sector median of 26x.
What is Merck & Co., Inc.'s Piotroski F-Score?
Merck & Co., Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MRK overvalued or undervalued?
A precise fair value estimate is not available for MRK. Trades at 16x earnings — near sector median of 26x.
How does MRK compare to other Health Care stocks?
Merck & Co., Inc. ranks #164 out of 1126 stocks in the Health Care sector, placing it in the top 15% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about MRK?
AlphaStocks evaluates MRK using five proven investment models. Piotroski: Neutral; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.4/10.

Similar Stocks

PARRFTIAZN

Compare MRK with

MRK vs PARRMRK vs FTIMRK vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer